Assignee
XUANZHU BIOPHARMACEUTICAL CO LTD
CN·5 granted patents·3 pending applications·1 citations·filing 2018–2025
Top patents by PatentIndex Score
8 records- 0170US11325982B2Biparatopic and multiparatopic antibodies with common light chain and method of useXUANZHU BIOPHARMACEUTICAL CO LTD·Filed 2018·Granted May 10, 2022·1 cites·18 claims
- 0259US2024238431A1Bispecific Antibody-Drug ConjugateXUANZHU BIOPHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0355US12378299B2CD80 variant proteins and uses thereofXUANZHU BIOPHARMACEUTICAL CO LTD·Filed 2020·Granted Aug 5, 2025·0 cites·10 claims
- 0453US11352358B2FXR agonistXUANZHU BIOPHARMACEUTICAL CO LTD·Filed 2018·Granted Jun 7, 2022·0 cites·6 claims
- 0552US12178807B2Macrocyclic tyrosine kinase inhibitor and uses thereofXUANZHU BIOPHARMACEUTICAL CO LTD·Filed 2019·Granted Dec 31, 2024·0 cites·10 claims
- 0652US2024075032A1A Pharmaceutical Composition for Treating CancerXUANZHU BIOPHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 0750US2025270224A1Polycyclic poly(adp-ribose) polymerase selective inhibitorXUANZHU BIOPHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 0849US11299474B2Crystal form targeting CDK4/6 kinase inhibitorXUANZHU BIOPHARMACEUTICAL CO LTD·Filed 2018·Granted Apr 12, 2022·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when XUANZHU BIOPHARMACEUTICAL CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →